miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 8 X users

Readers on

mendeley: 45 Mendeley

Summary X

So far, Altmetric has seen 11 X posts from 8 X users, with an upper bound of 24,566 followers.

Conclusion Our findings indicated that IDO1 suppressed the CD8+ T cell response in colon cancer (Logically, this is the case for all cancers. 🙂) https://t.co/lKW1E292hF

20 May 2022

Reply Repost Favourite

#JITC Research: miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer https://t.co/0cYX2j9xlO https://t.co/IpJAsRDr6O

30 Aug 2019

Reply Repost Favourite

RT @sitcancer: #JITC Research: miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer https://t.co/0cYX2j9xlO https:…

22 Aug 2019

Reply Repost Favourite

RT @sitcancer: #JITC Research: miR-448 targets IDO1 and regulates CD8+ T cell response in human colon cancer https://t.co/0cYX2j9xlO https:…

22 Aug 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.